Country: Canada
Language: English
Source: Health Canada
CLOTRIMAZOLE
BAYER INC
D01AC01
CLOTRIMAZOLE
1%
CREAM
CLOTRIMAZOLE 1%
TOPICAL
15G/50G
OTC
AZOLES
Active ingredient group (AIG) number: 0110231001; AHFS:
APPROVED
2019-05-01
_ _ _Canesten® Page 1 of 38_ PRODUCT MONOGRAPH CANESTEN® 6 DAY INTERNAL CREAM 1% Clotrimazole Vaginal Cream, Bayer Std. CANESTEN® 3 DAY INTERNAL CREAM 2% Clotrimazole Vaginal Cream, Bayer Std. CANESTEN® 1 DAY INTERNAL CREAM 10% Clotrimazole Vaginal Cream, Bayer Std. CANESTEN® COMBI 1 DAY INTERNAL + EXTERNAL CREAMS 10% & 1% Clotrimazole Vaginal Cream, Bayer Std. CANESTEN COMFORTAB 1 500mg Clotrimazole Vaginal Tablet, BP Std. CANESTEN COMFORTAB 3 200mg Clotrimazole Vaginal Tablets, BP Std. CANESTEN® COMBI 1 DAY 500mg Clotrimazole Vaginal Tablet, BP Std. 1% Clotrimazole Cream, Bayer Std. CANESTEN® COMBI 3 DAY 200mg Clotrimazole Vaginal Tablets, BP Std. 1% Clotrimazole Cream, Bayer Std. CANESTEN® EXTERNAL CREAM 1% Clotrimazole Cream, Bayer Std. CANESTEN® EXTERNAL ANTIFUNGAL CREAM 1% Clotrimazole Cream, Bayer Std. CANESTEN® EXTRA STRENGTH EXTERNAL ANTIFUNGAL CREAM 2% Clotrimazole Cream, Bayer Std (Clotrimazole) Bayer Standard Antifungal Agent Bayer Inc. 2920 Matheson Boulevard East Mississauga, Ontario L4W 5R6 Control No.: 254158 Date of Preparation: September 30 th , 2015 Date of Revision: January 6 th , 2022 _ _ _Canesten® Page 2 of 38_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ..................................................... 3 SUMMARY PRODUCT INFORMATION ............................................................................... 3 INDICATIONS AND CLINICAL USE ..................................................................................... 3 CONTRAINDICATIONS .......................................................................................................... 4 WARNINGS AND PRECAUTIONS ......................................................................................... 4 ADVERSE REACTIONS ........................................................................................................... 5 DRUG INTERACTIONS ........................................................................................................... 6 DOSAGE AND ADMINISTRATION .................. Read the complete document